TXMD Earnings TherapeuticsMD, Inc.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–20 of 20
| Q1 2026 | 2026-03-31 | 0.01 | 2026-05-12 | 10-Q |
| FY 2025 | 2025-12-31 | -0.05 | 2026-03-30 | 10-K |
| Q3 2025 | 2025-09-30 | 0.00 | 2025-11-12 | 10-Q |
| Q2 2025 | 2025-06-30 | -0.01 | 2025-08-12 | 10-Q |
| Q1 2026 | 2025-03-31 | -0.06 | 2026-05-12 | 10-Q |
| FY 2025 | 2024-12-31 | -0.19 | 2026-03-30 | 10-K |
| Q3 2025 | 2024-09-30 | -0.21 | 2025-11-12 | 10-Q |
| Q2 2025 | 2024-06-30 | -0.16 | 2025-08-12 | 10-Q |
| Q1 2025 | 2024-03-31 | -0.06 | 2025-05-13 | 10-Q |
| FY 2024 | 2023-12-31 | -0.99 | 2025-03-27 | 10-K |
| Q3 2023 | 2023-09-30 | -0.92 | 2023-11-14 | 10-Q |
| Q2 2024 | 2023-06-30 | -0.60 | 2024-08-12 | 10-Q |
| Q1 2023 | 2023-03-31 | -0.37 | 2023-05-15 | 10-Q |
| FY 2023 | 2022-12-31 | 11.96 | 2024-03-29 | 10-K |
| Q3 2023 | 2022-09-30 | 3.86 | 2023-11-14 | 10-Q |
| Q2 2023 | 2022-06-30 | 7.29 | 2023-08-14 | 10-Q |
| Q1 2023 | 2022-03-31 | -5.70 | 2023-05-15 | 10-Q |
| FY 2022 | 2021-12-31 | -21.66 | 2023-04-07 | 10-K |
| Q3 2022 | 2021-09-30 | -16.68 | 2022-11-14 | 10-Q |
| Q2 2022 | 2021-06-30 | -11.06 | 2022-08-15 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.